Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.29 USD | +2.24% | +20.65% | +0.17% |
May. 02 | UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating | MT |
May. 02 | Leerink Partners Adjusts Price Target on Bio-Techne to $95 From $85 | MT |
MarketScreener Editorial Features
Fed Day: The suspense is killing investors | November 02, 2022 at 10:19 am EDT | |
ANALYST RECOMMENDATIONS : BAT, Microsoft, NXP Semi, Snowflake, Clorox... | November 02, 2022 at 06:48 am EDT | |
Another case of good news is bad news | August 05, 2022 at 09:36 am EDT | |
Today on Wall Street: Yes, the global economic recovery is slowing | September 15, 2021 at 09:40 am EDT | |
ANALYST RECOMMENDATIONS : Chevron, Centene, Darktrace, Flutter, Malibu Boats... | September 15, 2021 at 05:02 am EDT | |
Global markets live: Kering, Delta Air Lines, Pfizer, Moderna, Sony... | August 25, 2021 at 11:43 am EDT |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- MarketScreener Editorial Features